跳至主要内容
临床试验/KCT0012389
KCT0012389进行中(未招募)3 期

A Multicenter, Prospective, Randomized, Single-Blind Clinical Trial to Evaluate Biomarker-Based Diagnosis of Critical Illness–Related Corticosteroid Insufficiency (CIRCI) and the Efficacy of Hydrocortisone Replacement Therapy in Patients with Severe Neurosurgical Condition (Blood biomarkEr-guided Adrenal COrtisol replacement in Neurocritical illness; BEACON study)

Asan Medical Center0 个研究点目标入组 356 人开始时间: 2026年8月17日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
356

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18(Year) 至 80(Year)(—)
性别
All

入选标准

  • Age =18 years and = 80 years
  • Acute traumatic brain injury [epidural hematoma (EDH), subdural hematoma (SDH), subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), intraventricular hemorrhage (IVH) and etc.], nontraumatic brain hemorrhage such as aneurysmal SAH, or ICH/IVH due to hypertensive, cerebral amyloid angiopathy, arteriovenous fistula (AVF), arteriovenous malformation (AVM), cavernous malformation (CM) and etc.
  • Underwent brain hemorrhage surgery [craniotomy and hematoma evacuation, decompressive craniectomy, extra ventricular drainage (EVD), burr hole trephination and etc.] within 48hours of hospital admission.
  • Glasgow coma score (GCS) on randomization: 5-13
  • Expected ICU stay > 72 hours

排除标准

  • Post-anoxic coma; status epilepticus without underlying brain injury; central nervous system (CNS) infections (community-acquired; hospital-acquired; ventriculitis; post-operative)
  • Known previous neurological disease, causing significant cognitive and/or motor strength deficit
  • Brain tumor (benign or malignant) bleeding
  • Previous medical history of adrenal insufficiency within previous 6 months
  • Current or history of (within 6 months) steroid administration due to underlying disease such as cardiac or pulmonary disease (transplantation, heart failure, interstitial lung disease, asthma, etc.), inflammatory disease (rheumatoid disease, lupus nephritis, etc.), dermatology disease (psoriasis, eczema, drug rash and etc.), spinal disease (spinal cord injury, degenerative disease), etc.
  • History of brain hemorrhage within 2 years.
  • Diagnosis of hematologic disease results in brain hemorrhage [acute myeloid leukemia, acute lymphocytic leukemia, or other disease-causing thrombocytopenia (< 50x10³/uL) or coagulopathy (INR >2)].
  • Current or history (within 3 months) of administrating antiplatelets (aspirin, clopidogrel or cilostazole) or anticoagulation (heparin or low-molecular weight heparin, vitamin K antagonist (warfarin) or direct oral anticoagulants)
  • Liver cirrhosis – Child’s class C liver disease
  • Status epilepticus or seizure disorder requiring anticonvulsant medication
  • GCS of 3 with both fixed and dilated pupils; Brain death or imminent death (within 24 hours)
  • Patients with a DNR (do not resuscitate) order
  • Multiple trauma (2 or more concurrent traumatic injuries)
  • Prior exposure to etomidate
  • Laboratory evidence of acute infection
  • Confirmed diagnosis with end-stage malignancy

研究者

相似试验